Haleon plc vs Kenvue Inc., two Household Products stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Haleon and Kenvue both sell consumer-health brands, Sensodyne and Advil on one side, Tylenol and Band-Aid on the other. Haleon earns a wider 15.23% margin but a lower 10.19% return on equity; Kenvue runs 10.61% margin and 15.29% on equity. Price favors Kenvue: 22.76 times earnings against Haleon's 39.25, and a heftier 4.31% dividend versus Kenvue's stronger cash yield of 4.96% against Haleon's 3.53%. Haleon carries no net debt while Kenvue runs a light 0.15. On book, Kenvue is cheaper at 3.46 times versus 3.98. Haleon is larger at $83.0B against $36.7B. Two close cousins, with the cheaper one paying more back.
Comparison updated 2026-07-11.
| Metric | HLN | KVUE |
|---|---|---|
| Price | $9.77 | $19.46 |
| Market cap | $87.8B | $37.4B |
| Sector | Household Products | Household Products |
| Stage | Mature | Mature |
| Implied growth (priced in) | +16.2% | -2.2% |
| P/E | 41.5 | 23.2 |
| P/B | 4.21 | 3.53 |
| P/S | 6.29 | 2.45 |
| EV/EBITDA | 24.5 | 11.9 |
| Revenue growth | +3.9% | +0.1% |
| Gross margin | 64.2% | 58.9% |
| Operating margin | 21.9% | 19.6% |
| Net margin | 15.2% | 10.6% |
| Return on equity | 10.2% | 15.3% |
| Return on assets | 5.2% | 6.0% |
| Return on invested capital | 11.4% | 15.2% |
| FCF yield | 3.3% | 4.9% |
| Dividend yield | — | 4.2% |
| Debt / equity | 0.00 | 0.15 |
| Current ratio | 0.92 | 0.98 |
| Altman Z (solvency) | 4.34 | 2.03 |
| Piotroski F (quality) | 8 / 9 | 8 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.